Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 701–800 of 1,001
Chetty, R., & Singh, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.067 · Cited by 25
Ricchelli, F., Fusi, P. A., Tortora, P., Valtorta, M., Riva, M., Tognon, G., Chieregato, K., Bolognin, S., & Zatta, P. F. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.012 · Cited by 25
Navale, G. R., Ahmed, I., Lim, M. H., & Ghosh, K. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401991 · Cited by 26
Tqemaladze, J. (2026) · Longevity Horizon · doi:10.65649/3hm9b025 · Cited by 24
Quantum dot: Heralding a brighter future in neurodegenerative disorders
Singh, A., Mallika, T. N., Gorain, B., Yadav, A. K., Tiwari, S., Flora, S. J. S., Shukla, R., & Kesharwani, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102700 · Cited by 27
[Retracted] Glymphatic System: Emerging Therapeutic Target for Neurological Diseases
Xuan, X., Zhou, G., Chen, C., Shao, A., Zhou, Y., Li, X., & Zhou, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6189170 · Cited by 26
Retractedα-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
Schmitz, M., Candelise, N., Canaslan, S., Altmeppen, H. C., Matschke, J., Glatzel, M., Younas, N., Zafar, S., Hermann, P., & Zerr, I. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00342-4 · Cited by 24
“Like most neurodegenerative diseases [78, 79], synucleinopathies are being recognized as proteinmisfolding diseases [80], defined by the template-induced conversion process of one or more proteins.”
BackgroundNew Strategy for the Generation of Specific d-Peptide Amyloid Inhibitors
Esteras‐Chopo, A., Pastor, M. T., Serrano, L. G., & de la Paz, M. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.028 · Cited by 24
Caruso, M., Gatto, E., Placidi, E., Ballano, G., Formaggio, F., Toniolo, C., Zanuy, D., Alemán, C., & Venanzi, M. (2013) · Soft Matter · doi:10.1039/c3sm52831f · Cited by 25
Xiong, R., Siegel, D. M., & Ross, D. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.04.016 · Cited by 25
Arslan, M. A., Chikina, M. D., Csermely, P., & Sőti, C. (2011) · The FASEB Journal · doi:10.1096/fj.11-186197 · Cited by 26
“Proteins may misfold due to inherent mutations (1), mistranslation (2), in response to denaturing stress, or from post-translational modifications (3–4) resulting in diverse non-native conformations.”
BackgroundNCLs and ER: A stressful relationship
Marotta, D., Tinelli, E., & Mole, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.04.003 · Cited by 26
“A common feature of many neurodegenerative disorders is the accumulation and deposit of misfolded and unfolded proteins, which trigger ER stress affecting neuronal homeostasis and lead to cell death [41].”
Disorder at the Tips of a Disease-Relevant Aβ42 Amyloid Fibril: A Molecular Dynamics Study
Ilie, I. M., & Caflisch, A. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b05236 · Cited by 25
Ashrafizadeh, M., Zarrabi, A., Najafi, M., Samarghandian, S., Mohammadinejad, R., & Ahn, K. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6732 · Cited by 28
“Protein misfolding and aggregation of Aβ result in the development of NDs such as AD and PD (Soto, 2003; Yamin, Ono, Inayathullah, & Teplow, 2008).”
BackgroundInhibiting protein–amyloid interactions with small molecules: A surface chemistry approach
Inbar, P., & Yang, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.067 · Cited by 24
BiP Clustering Facilitates Protein Folding in the Endoplasmic Reticulum
Griesemer, M., Young, C. L., Robinson, A. S., & Petzold, L. R. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003675 · Cited by 25
“Specifically, molecular chaperones dissociate aggregates, self-associating conglomerations of unfolded and misfolded proteins, which would otherwise interfere with the cell homeostasis leading to cell dysfunction and death [2].”
BackgroundChi, E. Y., Kendrick, B. S., Carpenter, J. F., & Randolph, T. W. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20488 · Cited by 24
Aggregation-prone Regions in HYPK Help It to Form Sequestration Complex for Toxic Protein Aggregates
Ghosh, D. K., Roy, A., & Ranjan, A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.007 · Cited by 23
Cysteamine functionalized MoS2 quantum dots inhibit amyloid aggregation
Sun, L., Qu, L., Yang, R., Yin, L., & Zeng, H. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.212 · Cited by 23
McIntosh, C. S., Li, D., Wilton, S. D., & Aung-Htut, M. T. (2021) · Biomedicines · doi:10.3390/biomedicines9111499 · Cited by 26
Depland, A. D., Stroganova, I., Wootton, C. A., & Rijs, A. M. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00253 · Cited by 24
A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration
Hamdan, Y. A., El‐Mansoury, B., Elouali, S., Rachmoune, K., Belbachir, A., Oudadesse, H., & Rhazi, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135356 · Cited by 26
A novel form of β-strand assembly observed in Aβ 33–42 adsorbed onto graphene
Wang, X., Weber, J. K., Liu, L., Dong, M., Zhou, R., & Li, J. (2015) · Nanoscale · doi:10.1039/c5nr00555h · Cited by 23
Saha, A., Mondal, G., Biswas, A., Chakraborty, I., Jana, B., & Ghosh, S. (2013) · Chemical Communications · doi:10.1039/c3cc41287c · Cited by 23
Monitoring Protein Misfolding by Site-Specific Labeling of Proteins In Vivo
Hsieh, T.-Y., Nillegoda, N. B., Tyedmers, J., Bukau, B., Mogk, A., & Krämer, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099395 · Cited by 25
“Protein aggregates have been linked to various human diseases ranging from cancer and type 2 diabetes to neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington disease and Amyotrophic lateral sclerosis [4,5].”
BackgroundALS Yeast Models—Past Success Stories and New Opportunities
Gregorio, S. E. D., & Duennwald, M. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00394 · Cited by 33
“Protein misfolding describes the conversion of proteins from their normal, mostly soluble and functional threedimensional conformations into aberrant, often insoluble, non-functional conformations (Soto, 2003; Soto and Estrada, 2008; Sweeney et al., 2017).”
Sanders, H. M., Jovcevski, B., Carver, J. A., & Pukala, T. L. (2020) · Biochemical Journal · doi:10.1042/bcj20190638 · Cited by 23
A missense mutation sheds light on a novel structure–function relationship of RANKL
Qiu, H., Qin, A., Cheng, T., Chim, S. M., Smithers, L., Chen, K., Song, D., Liu, Q., Zhao, J., Wang, C., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30045 · Cited by 23
“Undesired protein aggregation could be toxic and linked with many pathological changes (Nilsberth et al., 2001; Soto, 2003; Zhu, Lin, & Lal, 2000).”
BackgroundShin, Y., Cho, H., Choi, B. Y., Kim, J., Ha, J., Suh, S. W., & Park, S. B. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202013915 · Cited by 25
Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration
Lin, A., Peiris, N. J., Dhaliwal, H., Hakim, M., Li, W., Ganesh, S., Ramaswamy, Y., Patel, S., & Misra, A. (2021) · Cells · doi:10.3390/cells10030593 · Cited by 26
DNA Is a Template for Accelerating the Aggregation of Copper, Zinc Superoxide Dismutase
Jiang, W., Han, Y., Zhou, R., Zhang, L., & Liu, C. (2007) · Biochemistry · doi:10.1021/bi062234m · Cited by 23
Yuan, X., Wang, Z., Zhang, L., Sui, R., & Khan, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.041 · Cited by 22
A Review of Evolutionary Algorithms for Computing Functional Conformations of Protein Molecules
Shehu, A. (2015) · Methods in pharmacology and toxicology · doi:10.1007/7653_2015_47 · Cited by 22
Infrared Action Spectroscopy of Low-Temperature Neutral Gas-Phase Molecules of Arbitrary Structure
Yatsyna, V., Bakker, D. J., Salén, P., Feifel, R., Rijs, A. M., & Zhaunerchyk, V. (2016) · Physical Review Letters · doi:10.1103/physrevlett.117.118101 · Cited by 22
“diseases associated with the misfolding of proteins [1,2].”
Yeast as a model to study protein misfolding in aged cells
Gregorio, S. E. D., & Duennwald, M. L. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy054 · Cited by 26
Pollack, S. J., Trigg, J. E., Khanom, T., Biasetti, L., Marshall, K. E., Al‐Hilaly, Y. K., Rickard, J. E., Harrington, C. R., Wischik, C. M., & Serpell, L. C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.05.027 · Cited by 23
“A common pathological process amongst neurodegenerative diseases is the accumulation of amyloid aggregates formed by disease-specific proteins in the cytoplasm, nucleus or extracellular space [1].”
BackgroundDoes protein unfolding play a functional role in vivo?
Sharma, S., Subramani, S., & Popa, I. (2020) · FEBS Journal · doi:10.1111/febs.15508 · Cited by 22
Site-specific mitochondrial dysfunction in neurodegeneration
Vodičková, A., Koren, S. A., & Wojtovich, A. P. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.02.004 · Cited by 23
Tachykinin Neuropeptides and Amyloid β (25–35) Assembly: Friend or Foe?
Liu, X., Ganguly, P., Jin, Y., Jhatro, M. J., Shea, J., Buratto, S. K., & Bowers, M. T. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03845 · Cited by 25
Anticancer Therapeutic Strategies Targeting p53 Aggregation
Ferretti, G. D. S., Quarti, J., dos Santos, G., Rangel, L. P., & Silva, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911023 · Cited by 24
Morphology-Dependent Interactions between α-Synuclein Monomers and Fibrils
Pálmadóttir, T., Waudby, C. A., Bernfur, K., Christodoulou, J., Linse, S. S., & Malmendal, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065191 · Cited by 28
Bhowmik, S., Khanna, S., Srivastava, K., Hasanain, M., Sarkar, J., Verma, S. K., & Batra, S. (2013) · ChemMedChem · doi:10.1002/cmdc.201300302 · Cited by 22
Higgins, R., Kabbaj, M.-H., Hatcher, A., & Wang, Y. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191490 · Cited by 22
Spectroscopic Identification of Interactions of Pb2+ with Bovine Serum Albumin
Liu, Y., Zhang, L., Liu, R., & Zhang, P. (2011) · Journal of Fluorescence · doi:10.1007/s10895-011-0950-z · Cited by 22
“The main reason of many diseases (such as cataracts, mad cow disease and diabetes) is protein denaturation [1, 2].”
BackgroundSakurai, T., Kitadate, K., Nishioka, H., Fujii, H., Ogasawara, J., Kizaki, T., Sato, S., Fujiwara, T., Akagawa, K., Izawa, T., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s000711451300086x · Cited by 22
“Several neurodegenerative diseases including AD have been suggested to have an accumulation of misfolded proteins, which leads to altered neuronal connectivity, neuronal death and a dysfunctional process of ER-associated degradation machinery((26,55,56)), which shows that ER stress is involved in the pathology of AD a…”
BackgroundAcetylcholinesterase triggers the aggregation of PrP 106–126
Pera, M., Roman, S. A., Ratia, M., Camps, P., Muñoz‐Torrero, D., Colombo, L., Manzoni, C., Salmona, M., Badı́a, A., & Clos, M. V. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.187 · Cited by 22
Immunology of Apoptosis and Necrosis
Proskuryakov, S. Y., Gabai, V. L., Konoplyannikov, A. G., Александровна, З. И., & Kolesnikova, A. I. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0263-4 · Cited by 26
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 22
Kuhar, N., & Umapathy, S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02968 · Cited by 21
Advances in nonlinear optical microscopy techniques for in vivo and in vitro neuroimaging
Pallen, S., Shetty, Y., Das, S. K., Vaz, J. M., & Mazumder, N. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00832-7 · Cited by 26
“…(ALS), Huntington disease (HD), multiple sclerosis (MS), Parkinson’s disease (PD), and transmissible spongiform encephalitis (TSE) are a few of the ND characterized by progressive damage of the neurons leading to cognitive impairment and motor dysfunctions (Soto 2003; Weller and Budson 2018).”
BackgroundThe prion protein and its ligands: Insights into structure-function relationships
Shafiq, M., Vela, S. D., Amin, L., Younas, N., Harris, D. A., Zerr, I., Altmeppen, H. C., Svergun, D. I., & Glatzel, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119240 · Cited by 24
Cui, W.-B., Zhang, Z., Bai, X., Wang, S., Chen, X., Liu, X., Su, P., Zhi, D., Fei, D., Zhang, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710030 · Cited by 22
“Abnormal protein folding and deposition are common features of neurodegenerative diseases [37].”
BackgroundChwiej, J. G. (2009) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2009.11.002 · Cited by 24
The Role of Crowded Physiological Environments in Prion and Prion-like Protein Aggregation
Ma, Q., Hu, J.-Y., Chen, J., & Liang, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121339 · Cited by 21
“Obviously, as illustrated in Figure 2, the excluded-volume effects caused by macromolecular crowding could accelerate the nucleation and elongation steps of fibril formation of amyloidogenic proteins, such as human PrP, human Tau and human α-synuclein [72], while inhibit the nucleation or elongation step of fibril for…”
BackgroundProbing the role of λ6 immunoglobulin light chain dimerization in amyloid formation
Wolwertz, M. L., Nguyen, P. T., Quittot, N., & Bourgault, S. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.01.009 · Cited by 21
Effect of nitrogen-doped graphene quantum dots on the fibrillation of hen egg-white lysozyme
Zeng, H., Miao, M., Liu, Z., Yang, R., & Qu, L. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.022 · Cited by 21
Idrees, D., Rahman, S., Shahbaaz, M., Haque, M. A., Islam, A., Ahmad, F., & Hassan, M. I. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.010 · Cited by 21
“A complete understanding of protein folding and intermediates are of medical relevance, as the aggregation of misfolding proteins underlies various diseases, including some neurodegenerative disorders [16-20].”
BackgroundOladele, J. O., Oladiji, A. T., Oladele, O. T., & Oyeleke, O. M. (2021) · Biochemistry · doi:10.5772/intechopen.99976 · Cited by 26
Stoppini, M., Andreola, A., Foresti, G., & Bellotti, V. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.025 · Cited by 21
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric p -Phenylene Ethynylenes
Fanni, A. M., Okoye, D., Monge, F. A., Hammond, J., Maghsoodi, F., Martin, T. D., Brinkley, G., Phipps, M. L., Evans, D. G., Martinez, J. S., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c22869 · Cited by 20
Sun, R., Wan, W., Jin, W., Bai, Y., Xia, Q., Wang, M., Huang, Y., Zeng, L., Sun, J., Peng, C., et al. (2022) · Chemical Communications · doi:10.1039/d2cc00629d · Cited by 21
Ahanger, I. A., Ashraf, G. M., Sharma, A., & Islam, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230306085937 · Cited by 20
Deloncle, R., & Guillard, O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140765 · Cited by 20
“All of these abnormal -sheet deposits show antigenic structures analogic to normal brain proteins and have been suspected of resulting from physiological structures; it has even been suggested that they lead to neurodegeneration [5, 6].”
Phenotyping of Tianma-Stimulated Differentiated Rat Neuronal B104 Cells by Quantitative Proteomics
Sundaramurthi, H., Manavalan, A., Ramachandran, U., Hu, J., Sze, S. K., & Heese, K. (2011) · Neurosignals · doi:10.1159/000331492 · Cited by 20
Protein folding on rugged energy landscapes: Conformational diffusion on fractal networks
Lois, G., Bławzdziewicz, J., & O’Hern, C. S. (2010) · Physical Review E · doi:10.1103/physreve.81.051907 · Cited by 20
Woltjer, R. L., Reese, L. C., Richardson, B. E., Tran, H. T. D., Green, S., Pham, T., Chalupsky, M., Gabriel, I., Light, T. J., Sanford, L., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.10.012 · Cited by 23
“Common neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, other synucleinopathies, and various forms of frontotemporal lobar degeneration are characterized by the deposition of proteinaceous aggregates of specific proteins in cell type- and location-specific distributions that correspond to s…”
BackgroundAminophenol isomers unraveled by conformer-specific far-IR action spectroscopy
Yatsyna, V., Bakker, D. J., Feifel, R., Rijs, A. M., & Zhaunerchyk, V. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp07426f · Cited by 20
Donabedian, P. L., Evanoff, M., Monge, F. A., Whitten, D. G., & Chi, E. Y. (2017) · ACS Omega · doi:10.1021/acsomega.7b00231 · Cited by 21
Galimberti, D. R., Bougueroua, S., Mahé, J., Tommasini, M., Rijs, A. M., & Gaigeot, M. (2019) · Faraday Discussions · doi:10.1039/c8fd00211h · Cited by 22
Meneghetti, E., Gasperini, L., Virgilio, T., Moda, F., Tagliavini, F., Benetti, F., & Legname, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1505-6 · Cited by 21
MicroRNAs in Prion Diseases—From Molecular Mechanisms to Insights in Translational Medicine
Contiliani, D. F., Ribeiro, Y. D. A., de Moraes, V. N., & Pereira, T. C. (2021) · Cells · doi:10.3390/cells10071620 · Cited by 21
“Intriguingly, protein misfolding processes—exemplified by the prion protein—are also manifested in highly prevalent neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s diseases (PD) [102], amongst 20 human diseases referred to as protein misfolding disorders (PMDs).”
BackgroundIntrinsic Disorder in Proteins Associated with Neurodegenerative Diseases
Uversky, V. N. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_2 · Cited by 29
The Generic Nature of Protein Folding and Misfolding
Dobson, C. M. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_2 · Cited by 21
“Again, the major target of such strategies has been Alzheimer’s disease, and in vitro studies look very promising (Soto, 2003).”
BackgroundHeterogeneous cellular environments modulate one-hit neuronal death kinetics
Clarke, G. D., & Lumsden, C. J. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.009 · Cited by 20
Weiffert, T., Meisl, G., Flagmeier, P., De, S., Dunning, C. J. R., Frohm, B., Zetterberg, H., Blennow, K., Portelius, E., Klenerman, D., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00676 · Cited by 20
“It is generally believed that oligomeric species formed during the aggregation of Aβ are the toxic species and several possible mechanisms generating the toxicity have been identified (reviewed in (26) and (27)).”
BackgroundHow a Cell Deals with Abnormal Proteins
Aigelsreiter, A., Janig, E., Stumptner, C., Fuchsbichler, A., Zatloukal, K., & Denk, H. (2007) · Pathobiology · doi:10.1159/000103374 · Cited by 20
“The region affected determines the clinical symptoms [”
Top, A., Kiick, K. L., & Roberts, C. J. (2008) · Biomacromolecules · doi:10.1021/bm800056r · Cited by 20
Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases
Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 24
“( A higher resolution/colour version of this figure is available in the electronic copy of the article ). as potential causes of these diseases, leading to neuronal apoptosis, loss of synaptic connections, and brain damage [9].”
Porous Materials for Early Diagnosis of Neurodegenerative Diseases
Arghavani, P., Daneshgar, H., Sojdeh, S., Edrisi, M., Moosavi‐Movahedi, A. A., & Rabiee, N. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404685 · Cited by 20
Relationship between structural composition and material properties of polymorphic hIAPP fibrils
Lee, M., Chang, H. J., Kim, D., Lee, Y., Suh, H., Ahn, N., Yoon, G., & Na, S. (2015) · Biophysical Chemistry · doi:10.1016/j.bpc.2015.02.002 · Cited by 19
“origins of these diseases are the amyloid proteins developed by denatured and misfolded proteins [3,4], which disrupt and reduce the normal function of cells or proteins in the human body.”
BackgroundTetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide
Xu, J., Zhao, C., Huang, X., & Du, W. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.012 · Cited by 19
Decreased Proteasomal Function Induces Neuronal Loss and Memory Impairment
Tomaru, U., Ito, T., Ohmura, Y., Higashikawa, K., Miyajima, S., Tomatsu, R., Higashi, T., Ishizu, A., Kuge, Y., Yoshioka, M., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.10.004 · Cited by 20
Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders
Panda, C., & Mahapatra, R. K. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01184-2 · Cited by 23
“Accumulation of toxic misfolded proteins owing to the dysfunctional cellular debris clearance mechanisms can trigger the cascade of cytokines and other inflammatory factors produced by astroglial cells, responsible for irreparable neuronal damage (Soto 2003; Ransohoff 2016).”
BackgroundInterplay between Antimicrobial Peptides and Amyloid Proteins in Host Defense and Disease Modulation
Wani, N. A., Gazit, E., & Ramamoorthy, A. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c03123 · Cited by 21
Genesis and regulation of C-terminal cyclic imides from protein damage
Xu, W., Zhao, Z., Su, M., Jain, A. D., Lloyd, H. C., Feng, E. Y., Cox, N., & Woo, C. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415976121 · Cited by 21
Tortajada-Pérez, J., Carranza, A. D. V., Río, C. T.-D., Collado-Pérez, M., Millán, J. M., García‐García, G., & Vázquez‐Manrique, R. P. (2025) · Antioxidants · doi:10.3390/antiox14010078 · Cited by 23
Treatment of Prion Disease with Heterologous Prion Proteins
Skinner, P. J., Kim, H. O., Bryant, D. N., Kinzel, N. J., Reilly, C., Priola, S. A., Ward, A. E., Goodman, P. A., Olson, K. E., & Seelig, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131993 · Cited by 28
“Prion diseases belong to a growing family of disorders that are attributed to misfolding and aggregation of proteins, including Alzheimer’s disease, Parkinson’s disease and systemic amyloidosis [6,7].”
BackgroundGdnHCl-induced unfolding intermediate in the mitochondrial carbonic anhydrase VA
Idrees, D., Prakash, A., Haque, M. A., Islam, A., Hassan, M. I., & Ahmad, F. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.06.080 · Cited by 19
Spatially Separating the Conformers of a Dipeptide
Teschmit, N., Horke, D. A., & Küpper, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807646 · Cited by 23
Human cells adapt to translational errors by modulating protein synthesis rate and protein turnover
Varanda, A. S., Santos, M., Soares, A. R., Vitorino, R. M. P., Oliveíra, C., Oliveira, C., & Santos, M. A. S. (2019) · RNA Biology · doi:10.1080/15476286.2019.1670039 · Cited by 20
“Indeed, aggregates associated with neurological disorders can block proteasome activity and may activate mechanisms that repress protein synthesis [10,47], compromising adaptation to such aggregates [48,49].”
BackgroundJing, L., Cheng, S., Pan, Y., Liu, Q., Yang, W., Li, S., & Li, X. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02451-5 · Cited by 20
Guzzo, A., Delarue, P., Rojas, A. V., Nicolaï, A., Maisuradze, G. G., & Senet, P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.786123 · Cited by 22
“It plays a central role in the onset of the Parkinson disease (PD) and other neurological disorders, named synucleopathies (Soto, 2003; Chiti and Dobson, 2006; Stefanis, 2012; Chiti and Dobson, 2017; Tanudjojo et al., 2021).”
BackgroundMatrin3: Disorder and ALS Pathogenesis
Salem, A., Wilson, C. J., Rutledge, B. S., Dilliott, A. A., Farhan, S. M. K., Choy, W., & Duennwald, M. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.794646 · Cited by 23
“…et al., 2020) resulting in protein misfolding (Soto, 2003; Parakh and Atkin, 2016; Prasad et al., 2019), mislocalization (Tyzack et al., 2019; Suk and Rousseaux, 2020), and inclusion formation in motor neurons (Soto, 2003; Blokhuis et al., 2013; Jucker andWalker, 2018; Steinacker et al., 2019).”
BackgroundInfluentialGupta, M., Acharya, R., Mishra, A., Ramakumar, S., Ahmed, F., & Chauhan, V. S. (2008) · ChemBioChem · doi:10.1002/cbic.200800053 · Cited by 19
Molecular Mapping of the Recognition Interface between the Islet Amyloid Polypeptide and Insulin
Gilead, S., Wolfenson, H., & Gazit, E. (2006) · Angewandte Chemie · doi:10.1002/ange.200602034 · Cited by 19
Neurotrophe Naturstoffe – ihre Chemie und Biologie
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie · doi:10.1002/ange.201302268 · Cited by 18
Shah, S. Z. A., Zhao, D., Taglialatela, G., Khan, S. H., Hussain, T. A., Dong, H., Lai, M., Zhou, X., & Yang, L. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0500-0 · Cited by 19
“homeostasis is observed in all protein misfolding neurodegenerative diseases [37, 38].”
BackgroundRetractedRohmer, M., Freudenberg, J., & Binder, W. H. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200344 · Cited by 18
The Potential of Mesenchymal Stem Cell in Prion Research
Mediano, D. R., Sánz-Rubio, D., Ranera, B., Bolea, R., & Martín‐Burriel, I. (2014) · Zoonoses and Public Health · doi:10.1111/zph.12138 · Cited by 21
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.